person

Lyubomir H.

Country
Bulgaria
Department
BG001

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
10
Sites with multiple studies

Has run more than one trial at 10 of 99 partner sites.

Specializations

Infectious Disease Research

This investigator specializes in studying influenza virus infections and preventive vaccine development, with particular attention to vulnerable populations aged 50 years and above.

  • Seasonal Influenza Prevention
  • Vaccine Immunogenicity Assessment
  • Respiratory Disease Management

The research explores both traditional and innovative vaccine technologies, including mRNA-based vaccine platforms and adjuvanted vaccine formulations.

Vaccine Development

The investigator focuses on comparative evaluation of different vaccine technologies, including studies of MF59-adjuvanted subunit vaccines against conventional non-adjuvanted alternatives.

  • Vaccine Safety Assessment
  • Clinical Efficacy Studies
  • Elderly Population Medicine

Special emphasis is placed on developing protective strategies for adults aged 65 and older against respiratory infections.

Metabolic Disorders

The investigator conducts research in the treatment of severe hypertriglyceridemia, exploring novel therapeutic approaches using innovative pharmaceutical compounds.

  • Lipid Metabolism
  • Triglyceride Management
  • Cardiovascular Risk Factors

The research includes evaluation of new therapeutic agents for managing elevated triglyceride levels in affected patients.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.